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utilized in 58.1% of cases. Furthermore, a 2 stent strategy was used as the initial
strategy in 40.3% of procedures with final kissing balloon inflation successfully
performed in 74.2%. At 30 days, there was one (1.6%) incidence of TLF, with no other
adverse events. Overall, all cause mortality occurred in 6.5% at follow-up with no MI
or definite/ probable stent thrombosis. Moreover, MACE occurred in 21.0% of patients,
with TVR in 16.1%, TLF in 4.8% and TLR in 4.8%.
Conclusion: The new EES appear to be safe and effective for the treatment of
unprotected left main stem stenosis at median follow-up of 723.5 days. Clearly this
needs to be demonstrated at longer-term follow-up.
TCT-310
Treatment of bifurcations with the dedicated Sideguard nitinol stent compared
with conventional 2-stent strategies
Nicolas Foin1, Carlo Di Mario1, Ajay K Jain2
1Imperial College and Royal Brompton Hospital, London, United Kingdom; 2Barts
and The London NHS Trust, London, United Kingdom
Background: Clinical observations revealed that strut malapposition and Side Branch
(SB) occlusion is common after bifurcations treatment with PCI. Current techniques
for bifurcation stenting often fail to ensure scaffolding of the SB and complete
apposition of stent struts in the bifurcation. Struts floating in the ostium can disturb
blood flow and increase risk of focal restenosis and stent thrombosis, limiting the
success of stent procedures in bifurcations lesions.
Methods: The dedicated Sideguard stent (Cappella Medical Device, Galway, Ireland)
was deployed as SB stent in 2 coronary bifurcation bench models (45° and 70° SB
angle). Commercially available drug eluting stents were used as Main Vessel stents
and malapposition quantified from micro-CT with the Sideguard dedicated SB nitinol
stent (2.5mm and 2.75mm, n=5) was compared with conventional 2-stent stenting
techniques (crush, n=5; culotte, n=3 and t-stenting, n=2).
Results: Rate of malapposed struts within the bifurcation after kissing balloon post-
dilatation using the same balloon sizes and inflation pressure was on average 36.7 ±
8.6 % with conventional techniques, reduced to 16.4 ± 7.5 % with the Sideguard
(p=0008). Area of the SB ostium jailed by stent struts was reduced to 8.3 % when using
the Sideguard compared to an average of 32.8 % after conventional 2-stent techniques
(p=0.0004). Furthermore, the Sideguard device avoid overlap of multiple stent layers,
resulting in less strut malapposition in the Main Vessel proximal to the SB compared
to crush or culotte technique (8.2 % vs. 39.1.%, p=0.0018 and 26.1 %, p=0.024).
Conclusion: Use of the Sideguard as SB stent may offer complete stent scaffolding of
the SB ostium while reducing struts malapposition in the bifurcation ostium and
proximal to the SB compared to conventional 2-stent approaches.
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Healing Responses After Bifurcation Stenting with the Dedicated TRYTON
Side-Branch Stent in Combination with XIENCE V Stents: an Angiography
and Optical Coherence Tomography Study
Christophe L Dubois, Tom Adriaenssens, Giovanni Ughi, Mark Coosemans, Bert
Ferdinande, Peter Sinnaeve, Walter Desmet
University Hospital Leuven, Department of Cardiovascular Diseases, Leuven,
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Background: There is an ongoing controversy regarding the efficacy and safety of
different bifurcation stenting techniques, and dedicated bifurcation stents have been
proposed as a potential alternative. We evaluated healing responses, as assessed with
optical coherence tomography (OCT), and clinical and angiographic outcome, 9
months after percutaneous coronary intervention (PCI) of coronary bifurcation lesions
with the dedicated TRYTON Side-Branch Stent.
Methods: Consecutive patients with coronary bifurcation lesions and significant
involvement of the side-branch underwent PCI with the TRYTON Stent and an
additional XIENCE V stent in a modified culotte technique. Primary endpoint of the
study was the ratio of uncovered to total stent struts at the lesion site, as assessed with
OCT 9 months after PCI. Secondary endpoints were the rate of in-segment restenosis
and late luminal loss at 9 months, as assessed with quantitative coronary angiography
(QCA). Clinical endpoints included the rate of target lesion revascularization (TLR),
target vessel revascularization (TVR), myocardial infarction (MI), cardiac death, and
stent thrombosis at 1 year.
Results: Between January and June 2010, 20 patients (mean age 68±10y, 65% male,
25% diabetes, 95% LAD/Diagonal) were included. Implantation of the TRYTON stent
was successful in 18 (90%). Failures were due to inability to cross the bifurcation with
TRYTON in 1, TRYTON dislodgment during removal of jailed wire in the other.
Angiographic follow-up was available in 18 (90%) at 9.7±1 months. OCT was
performed in 15 (75%, two additional patients with severe restenosis precluding OCT,
1 without TRYTON stent). At 1 year, 6 patients had undergone TVR (30%), of which
4 were TLR (20%). Three of these restenoses were silent. Four occurred at the proximal
main branch stent edge. Five patients suffered MI (25%), 4 of which were
periprocedural and without clinical consequences. There were no deaths nor stent
thromboses.
Conclusion: In patients with complex bifurcation anatomy, a TLR rate of 20% was
seen after implantation of the dedicated first generation TRYTON Side-Branch Stent
in combination with XIENCE V stents. OCT and QCA may help to understand healing
responses and failures. Nine months’ OCT and angiographic follow-up will be
presented.
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Effect and mechanisms of coronary bifurcation angle from 3-D on clinical
outcomes after percutaneous treatment with stents-results from DKCRUSH-II
trial
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Background: The role of bifurcation angle (BA) in predicting clinical outcomes after
stenting bifurcation lesions remains to be unclear. The aim of the present study was to
investigator the dynamic change of BA and its predictive value for patients with
coronary bifurcation lesions treated by stents.
Methods: 347 patients were completely studied from our DKCRUSH-II study. BA
was calculated by 3-D quantitative coronary analysis. Primary endpoint was the
occurrence of composite major adverse cardiac events(MACE) at 12-month, including
cardiac death, myocardial infarction(MI) and target vessel revascularization(TVR).
End point was the rate of binary restenosis and stent thrombosis at the end of clinical
follow-up.
Results: Stenting was associated with increase of proximal BA(153.660±21.490) and
the reduction of distal BA. The cut-off value of distal BA for predicting MACE was
600. Distal BA in <600 group had slight reduction after stenting(-1.96±13.580 vs. -
12.12±23.580, p<0.001); two-stent technique was associated with significant reduction
of distal BA (-4.05±14.200),compared to PS group[1.55±11.73,p=0.003); the TLR,
TVR and MACE rate was 16.5%,19.0% and 21.5% in one-stent group (n=79),
compared to 3.8% (p=0.002),7.5%(p=0.016) and 9.8%(p=0.024) in two-stent group
(n=133), respectively; further, the rate of TLR, TVR and MACE in DK group (n=108)
was 2.8%, 6.5%, and 8.3%, compared to 14.4%, 17.3%, and 20.2% in PS group
(p=0.003, =0.019, and =0.017). Among patients in≥600 group, there were no
differences in distal BA, ST, MI, MACE, death, TLR, TVR between one-vs. two-stent
groups; after stenting procedure, there was only slight change of distal BA in LAD-
LCX subgroup (from 88.540±21.330 at baseline to 82.440±31.720 post-stenting),
compared to either LAD-D, or LCX-OM,or RCAd (all p<0.001).
Conclusion: Complex stenting was associated with significant reduction of distal BA.
Two-stent, as DK crush stenting, had reduced rate of MACE in patients in <600 group,
compared to one-stent technique.
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Clinical Outcomes of Left Main Crossover Stenting without Opening of Left
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Background: Simple crossover stenting in non-left main (LM) bifurcation lesion
without opening of stent strut in the ostium of side branch demonstrated a favorable
outcome. However the safety and efficacy of the same strategy for LM crossover
stenting has not been validated yet.
Methods: Among the patients who successfully underwent LM to LAD crossover
stenting due to LM or ostial left anterior descending coronary artery (LAD) disease,
the clinical outcomes of the patients with non-significant residual stenosis (<70%) in
ostial LCX after stenting were evaluated. The 3-year outcome analyzed by the
composite of cardiac death,, myocardial infarction, repeat revascularization, and stent
thrombosis.
Results: Among the included 106 patients, 88 (83%) patients were deferred without
any additional procedure in ostial LCX. Preinterventional and post-stent % diameter
stenosis (DS) of ostial LCX were 23±14% and 33±16%, respectively (p<0.001). The
rate of MACE was 11.4 % (cardiac death 4.5%, myocardial infarction 2.27%, repeat
revascularization 9.1%, and stent thrombosis 2.27%, respectively). Purely ostial LCX
related MACE was 20%. Event free survival curve was obtained (see the attached
figure).
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Conclusion: Although the ostial strut of LCX was not opened after LM crossover
stenting, the clinical outcome of this strategy demonstrated safe and favorable clinical
outcomes.
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Predictive Factors of Long-term Outcomes after Crush Technique for
Bifurcation Coronary Lesions
Hae-Geun Song, Young-Hak Kim, Kyung-Min Park, Jung-Min Ahn, Jong-Young Lee,
Won-Jang Kim, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook
Park, Seung-Jung Park
Asan Medical Center, Seoul, Republic of Korea
Background: The long-term outcomes and its predictive factors after crush technique
for bifurcation lesions remain uncertain.
Methods: Consecutive 273 patients with 278 bifurcation lesions who received crush
stenting were prospectively enrolled. Final kissing balloon dilatation (FKBD) after
crushing was attempted in all patients. Guidance of intravascular ultrasound was
attempted in all procedures. Angiographic analysis was performed using the dedicated
bifurcation software. Analysis was performed per a lesion basis.
Results: FKBD was successfully performed in 94.2% of lesions and non-compliant
balloon was used in 45.3% for the main branch and 36.7% for the side branch. For the
median of 18 months follow-up, major adverse cardiac events (MACE) including
death, myocardial infarction, and target vessel revascularization (TVR) occurred in 21
lesions. Freedom from death, myocardial infarction, TVR and MACE were 97.0%,
96.3%, 83.7% and 80.4%, respectively. Angiographic follow-up was performed in
72.7% of lesions and angiographic restenosis was identified in 9.4% of lesions. In
multivariate Cox model, diabetes mellitus FKBD and pre-procedure MLD at proximal
main branch were independently associated with MACE.
Conclusion: Crush technique under the guidance of intravascular ultrasound has
favorable long-term outcomes when FKBD is successfully performed.
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Acute Myocardial Infarction due to Unprotected Left Main Coronary Artery
Occlusion Treated with Primary Angioplasty
Ivan Gomez, Victor Jimenez, Jose A Baz, Antonio de Miguel, Guillermo Bastos,
Alberto Ortiz, Andres Iñiguez
Hospital Meixoeiro, Vigo, Spain
Background: ST-segment elevation acute myocardial infarction (STEMI) due to
unprotected left main coronary occlusion (ULMCO) is a dramatic and catastrophic
entity with high risk of out-of-hospital sudden death. Therefore very few data have
been published regarding the effectiveness of primary percutaneous coronary
intervention (PPCI) in this group of patients. The objective was to determine the
incidence and predictors of in-hospital mortality.
Methods: Single-center retrospective study of 2018 consecutive patients who
underwent PPCI for STEMI from January 2006 to May 2011
Results: Among 2018 STEMI patients admitted for PPCI, 32 (1.58%) had acute
subtotal or total ULMCO. Mean age was 63.9 ± 15.1 years, 23 (72%) were male, 6
(19%) had diabetes, 10 (31%) smokers. Angiography showed 4 (12.5%) proximal, 3
(9.3%) middle, 22 (69%) distal and 3 (9.3%) diffuse ULMCO. Initial Killip class I-III
in 18 (56.2%) and Killip class IV in 14 (43.8%). In-hospital mortality occurred in 16
(50%) patients and only one (3.1%) at 1 year. Univariate analysis determined type of
stent deployed, severity of stenosis and Killip class at admission as predictors of in-
hospital mortality. The Cox regression model identified as independent predictor of
in-hospital mortality only Killip class at admission (RR 2.47 [95% CI 1.25 - 4.89]).
Conclusion: Among patients with STEMI due to thrombotic ULMCO undergoing
primary angioplasty in our center, in-hospital mortality was 50%, but with very low
mortality at 1-year follow up. Only Killip class at admission was identified as
independent predictor of in-hospital mortality.
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First Generation versus Newer Generation Drug-eluting Stents in Unprotected
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Background: For the treatment of unprotected left main coronary artery (ULMCA)
disease, although coronary artery bypass grafting (CABG) is recommended by the
current practice guidelines, percutanous coronary intervention (PCI) with drug-eluting
stents (DES) has recently emerged as an alternative to CABG. However, there are
limited data regarding whether the newer generation DESs is associated with better
outcomes as compared with first generation DESs in treating ULMCA disease.
Methods: A total 162 patients (pts) who underwent PCI with DESs for ULMCA were
enrolled for current study. We compared angiographic and clinical outcomes of first
generation DESs [Paclitaxel-eluting stents (Taxus™) and Sirolimus-eluting stents
(Cypher™)] versus newer generations DESs [Zotarolimus-eluting stents (Endeavor
Resolute™) and Everolimus-eluting stents(Promus Element™ and Xience™).
Results: Baseline characteristics were similar between the two groups except that
newer generations DESs group had a higher male gender (84.2% vs.65%, p=0.025).
At index procedure, there was trend towards higher use of IVUS in newer generations
DESs group (64.9% vs. 47.6%, p=0.065) whereas more use of final kissing balloon in
first generation DESs group (44.4% vs. 28.9%, p=0.091). However, at six months,
there were no differences in major angiographic outcomes and similar results were
found in major clinical outcomes up to twelve months. Interestingly, the DES
associated aneurysms were found only after the first generation DESs implantation
(Table).
Conclusion: In the current study, there were no significant differences between first
& newer generations DESs at 6 months angiographic and 12 months clinical outcomes
following ULMCA intervention.
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